Please wait while we open this resource.
K
Clinical reviews
THE ROLE OF SGLT-2 INHIBITORS IN THE MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES
KIRUDDU NATIONAL REFERRAL HOSPITAL
PDF49 pages2.0 MB
The document provides a comprehensive overview of SGLT-2 inhibitors, detailing their pharmacological effects, clinical trial outcomes, and recommendations from global clinical guidelines. It emphasizes the importance of these medications in improving glycemic control, reducing cardiovascular risks, and slowing the progression of kidney disease in patients with type 2 diabetes. Additionally, it addresses potential side effects and considerations for patient management.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology